Trial intelligence / Profile preview

BMG0703 mouthwash for gingivitis

NCT04438421Phase 3Unknown

Sponsor
University of Milan
Start
Jun 2020
Primary completion
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial in gingivitis (3 arms), sponsored by University of Milan. Primary endpoints: Bleeding index at 30 days and Plaque index at 30 days. Status: unknown.

02

Conditions

gingivitis

Beyond the preview

Go deeper on NCT04438421.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04438421.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call